Tower Research Capital (TRC)’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-941
| Closed | -$18K | – | 6599 |
|
|
2023
Q1 | $18K | Sell |
941
-1,654
| -64% | -$28.6K | ﹤0.01% | 3603 |
|
|
2022
Q4 | $35K | Sell |
2,595
-2,075
| -44% | -$28.9K | ﹤0.01% | 2624 |
|
|
2022
Q3 | $64K | Buy |
4,670
+2,394
| +105% | +$35.6K | ﹤0.01% | 2951 |
|
|
2022
Q2 | $33K | Buy |
2,276
+1,855
| +441% | +$32.2K | ﹤0.01% | 3290 |
|
|
2022
Q1 | $10K | Sell |
421
-5,988
| -93% | -$116K | ﹤0.01% | 4400 |
|
|
2021
Q4 | $121K | Buy |
6,409
+5,633
| +726% | +$150K | ﹤0.01% | 2112 |
|
|
2021
Q3 | $25K | Sell |
776
-3,228
| -81% | -$120K | ﹤0.01% | 3543 |
|
|
2021
Q2 | $171K | Buy |
4,004
+377
| +10% | +$14.7K | ﹤0.01% | 2036 |
|
|
2021
Q1 | $140K | Buy |
3,627
+2,299
| +173% | +$97.9K | ﹤0.01% | 2316 |
|
|
2020
Q4 | $58K | Sell |
1,328
-28,563
| -96% | -$1.07M | ﹤0.01% | 2960 |
|
|
2020
Q3 | $1.18M | Buy |
29,891
+26,027
| +674% | +$841K | 0.01% | 832 |
|
|
2020
Q2 | $121K | Buy |
+3,864
| New | +$144K | 0.01% | 2293 |
|
|
2019
Q4 | – | Sell |
-697
| Closed | -$33K | – | 4623 |
|
|
2019
Q3 | $33K | Buy |
697
+147
| +27% | +$6.91K | ﹤0.01% | 2117 |
|
|
2019
Q2 | $24K | Buy |
550
+513
| +1,386% | +$19.9K | ﹤0.01% | 2066 |
|
|
2019
Q1 | $1K | Buy |
+37
| New | +$1.25K | ﹤0.01% | 3664 |
|
|
2018
Q4 | – | Sell |
-854
| Closed | -$33K | – | 4527 |
|
|
2018
Q3 | $33K | Sell |
854
-14,171
| -94% | -$524K | ﹤0.01% | 2022 |
|
|
2018
Q2 | $486K | Buy |
+15,025
| New | +$413K | 0.03% | 657 |
|
|
2018
Q1 | – | Sell |
-39
| Closed | -$1K | – | 4015 |
|
|
2017
Q4 | $1K | Sell |
39
-3,991
| -99% | -$101K | ﹤0.01% | 3390 |
|
|
2017
Q3 | $113K | Buy |
+4,030
| New | +$123K | 0.01% | 1240 |
|
|
2017
Q2 | – | Sell |
-2,730
| Closed | -$77K | – | 3648 |
|
|
2017
Q1 | $77K | Buy |
2,730
+1,670
| +158% | +$44.4K | 0.01% | 550 |
|
|
2016
Q4 | $25K | Buy |
+1,060
| New | +$26K | ﹤0.01% | 1948 |
|
|
2016
Q3 | – | Sell |
-4,008
| Closed | -$73K | – | 4690 |
|
|
2016
Q2 | $73K | Buy |
+4,008
| New | +$62.6K | 0.01% | 1308 |
|
|
2016
Q1 | – | Sell |
-529
| Closed | -$8K | – | 5169 |
|
|
2015
Q4 | $8K | Sell |
529
-5,182
| -91% | -$76.9K | ﹤0.01% | 2471 |
|
|
2015
Q3 | $91K | Buy |
5,711
+3,889
| +213% | +$98K | 0.01% | 615 |
|
|
2015
Q2 | $48K | Buy |
1,822
+1,604
| +736% | +$51.8K | ﹤0.01% | 1401 |
|
|
2015
Q1 | $9K | Buy |
+218
| New | +$7.51K | ﹤0.01% | 2890 |
|
|
2014
Q4 | – | Sell |
-1,155
| Closed | -$28K | – | 4880 |
|
|
2014
Q3 | $28K | Buy |
+1,155
| New | +$32.9K | ﹤0.01% | 2037 |
|
|
2013
Q4 | – | Sell |
-693
| Closed | -$14K | – | 5021 |
|
|
2013
Q3 | $14K | Buy |
+693
| New | +$14.4K | ﹤0.01% | 2978 |
|
Other funds holding CSII
Tower Research Capital (TRC)'s CSII Position: Q2 2023 in Review
Tower Research Capital (TRC) sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 941 shares — an estimated $18K sold.
Tower Research Capital (TRC) first reported a position in CSII in Q3 2013 and held it in 28 quarters. The position peaked at $1.18M in Q3 2020. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.
- Tower Research Capital (TRC) reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 941 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $18K.
- Tower Research Capital (TRC) first reported a position in Cardiovascular Systems, Inc. in Q3 2013 and held it in 28 quarters.
- Tower Research Capital (TRC)'s Cardiovascular Systems, Inc. position peaked at $1.18M in Q3 2020.
- 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.